Norris Medicines Share Price Today | Stock Price & Norris Medicines Share Screener
As of October 5, 2026, the live Norris Medicines share price (BSE: NORRIS) is ₹16.07, down 1.41% from the previous close, with shares trading between ₹15.49 and ₹16.50 in today's trading session, and a 52-week range of ₹12.31–₹19.69. Check NORRIS annual price range for the annual price range and momentum. Use the Norris Medicines stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Norris Medicines opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Norris Medicines Share Price Chart
Track the current stock price of Norris Medicines with an interactive chart. Analyse NORRIS share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Norris Medicines stock quote in one place.
The quote of ₹16.07 sits between the 52-week low of ₹12.31 and the 52-week high of ₹19.69, and the latest session moved -1.41% from the previous close.
Norris Medicines Company Profile - Fundamental Screener
Screen Norris Medicines company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for NORRIS shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Commercial Services sector and the Trading & Distributors industry, and it trades under ISIN INE744C01029.
Company Details
Classification
Identifiers and Leadership
Norris Medicines Balance Sheet Screener
Screen NORRIS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹13, down from ₹14 in 2025.
Latest statistics put total assets at ₹13 and shareholder funds at ₹-15.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 13 | 14 | 14 | 14 | 14 | 20 | 21 | 20 | 21 | 22 |
| Current Assets | 6 | 6 | 6 | 5 | 4 | 8 | 7 | 7 | 8 | 9 |
| Fixed Assets | 5 | 5 | 6 | 7 | 7 | 8 | 8 | 9 | 9 | 10 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 19 | 19 | 19 | 18 | 18 | 16 | 15 | 11 | 8 | 8 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | -15 | -15 | -14 | -12 | -11 | -7 | -3 | 0 | 2 | 5 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves & Surplus | -25 | -25 | -24 | -22 | -21 | -17 | -12 | -10 | -8 | -5 |
Norris Medicines Income Statement Screener - Profit & Revenue Analysis
Screen Norris Medicines income statement and profit fundamentals. Analyze NORRIS quarterly results. Norris Medicines reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹8 and net profit was ₹0, equal to earnings per unit of ₹-0.40, at an operating margin of -1%.
In that period expenses were ₹7, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹8 and net profit of ₹0.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||
| Revenue | 8 | 8 | 6 | 6 | 8 | 10 | 12 | 8 | 16 | 14 | 21 | 19 | 19 |
| Expenses | 7 | 8 | 6 | 6 | 7 | 10 | 14 | 10 | 17 | 16 | 21 | 18 | 17 |
Operating Costs and Margins | |||||||||||||
| EBITDA | 0 | 1 | 0 | 0 | 1 | 0 | -2 | -2 | -1 | -2 | 0 | 1 | 2 |
| Operating Profit % | -1.00% | 8.00% | -5.00% | -3.00% | 11.00% | -1.00% | -14.00% | -27.00% | -4.00% | -14.00% | 0.00% | 4.00% | 9.00% |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 1 | 0 | 0 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Profit and Earnings | |||||||||||||
| Profit Before Tax | 0 | 0 | -1 | -1 | -1 | -2 | -4 | -4 | -2 | -3 | -1 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 1 | 1 | 1 | -1 | 0 | -1 | 0 | 0 | 1 |
| Net Profit | 0 | 0 | -1 | -1 | -2 | -3 | -5 | -3 | -2 | -3 | -1 | 0 | -1 |
| EPS | -0.40 | -0.28 | -1.24 | -1.19 | -1.75 | -3.26 | -4.96 | -2.84 | -1.68 | -2.51 | -0.77 | 0.04 | -1.04 |
Norris Medicines Cash Flow Screener - Liquidity Fundamentals
Screen NORRIS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹1.
Over the same period, investing activities provided ₹0 and financing activities used ₹1.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 1 | 1 | 0 | 1 | -1 | 1 | -3 | -2 | 1 | -1 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 |
Financing and Net Cash | ||||||||||
| Financing Activities | -1 | -1 | 0 | -1 | 1 | -1 | 3 | 2 | -1 | 3 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Norris Medicines Shareholding Pattern Screener
See Norris Medicines shareholding pattern with promoter, FII, and DII holdings. Check Norris Medicines promoter holding and ownership changes for NORRIS on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 34.01%, foreign institutions 0.00%, domestic institutions 0.07% and the public 20.78%, spread across 25,777 shareholders.
The shareholder count was 25,777 in 2026-Mar, compared with 25,777 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 34.01% | 34.01% | 34.00% | 34.00% | 34.00% | 34.00% | 34.01% | 34.01% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 20.78% | 20.78% | 20.76% | 20.78% | 20.79% | 20.79% | 20.70% | 20.71% |
| Other Holding | 45.14% | 45.14% | 45.17% | 45.15% | 45.14% | 45.14% | 45.22% | 45.21% |
| Shareholder Count | 25,777 | 25,777 | 25,815 | 25,950 | 25,895 | 25,791 | 25,517 | 25,400 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Norris Medicines. Norris Medicines dividend yield can be compared with peers and other stocks in the market.
Norris Medicines Stock Index Membership - Nifty & Sensex
See which indices include Norris Medicines stock. Check NORRIS index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Norris Medicines Market Events Screener - Corporate Actions
Get Norris Medicines corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Norris Medicines stock events that may affect NORRIS share price, along with derivatives, futures and options activity and sector gainers.
13 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.
It is followed by Quarterly Result Announcement dated August 14, 2026 and Quarterly Result Announcement dated May 30, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-29 | 2026-09-29 | Annual General Meeting | NA | 30.97% |
| 2026-08-14 | 2026-08-14 | Quarterly Result Announcement | NA | 9.39% |
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | 1.92% |
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | 2.57% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -0.42% |
| 2025-09-29 | 2025-09-29 | Annual General Meeting | NA | 3.69% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 2.16% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 6.26% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -2.88% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 15.67% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | 0.97% |
| 2024-01-30 | 2024-01-30 | Extraordinary General Meeting | NA | 66.24% |
| 2023-12-14 | 2023-12-14 | Annual General Meeting | NA | 9.29% |
Norris Medicines Competitors Screener - Peer Stocks Comparison
Screen NORRIS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Commercial Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Redington | 31,111 | 21.15 | 119,347 | 19.87% | 1,284 | 58.27 |
| MMTC | 8,444 | 19.10 | 181 | -31.28% | 387 | 29.03 |
| MSTC | 4,969 | 21.48 | 453 | 16.90% | 218 | 46.76 |
| Ravindra Energy | 2,918 | 49.78 | 0 | 107.17% | 0 | 41.56 |
| Vintage Coffee & Beverages | 2,621 | 33.33 | 553 | 76.98% | 72 | 55.51 |
| BN Agrochem | 2,228 | 125.69 | 874 | 137.94% | 34 | 57.98 |
| Creative Newtech | 1,621 | 22.11 | 2,718 | 50.85% | 70 | 43.69 |
| Elitecon International | 1,245 | 6.85 | 5,075 | 820.35% | 185 | 30.46 |
| TCC Concept | 1,128 | 17.80 | 0 | % | 0 | 43.69 |
| Pervasive Commodities | 1,090 | 44 | 43.56% | 0 | 100.00 |
Norris Medicines Company Announcements - News & Reports Screener
Screen NORRIS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 1, 2026.
The next most recent announcements are dated October 1, 2026 and October 1, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-01 | Scrutinizers Report And Voting Results Of The 35Th AGM Of The Company Held 29Th September 2026 | - |
| 2026-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-10-01 | Outcome And Proceeding Of The 35Th Annual General Meeting | - |
| 2026-10-01 | Proceeding Of The Annual General Meeting | - |
| 2026-10-01 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-28 | Closure of Trading Window | - |
| 2026-09-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-04 | Reg. 34 (1) Annual Report. | - |
| 2026-09-04 | Notice Of 35Th Annual General Meeting Of The Company For The Financial Year 2025-26 | - |
| 2026-09-04 | Intimation Of Book Closure For 35Th AGM Of The Company. | - |
| 2026-09-03 | Board Meeting Outcome for Of Board Meeting Held On Thurday 03Rd September 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-14 | Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-08-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On August 14 2026 Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | - |
| 2026-08-08 | Board Meeting Intimation for Under Regulation 29 Of SEBI Listing Obligation And Disclosure Requirements 2015 For Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-07-30 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-07-30 | Board Meeting Outcome for Outcome Of The Board Meeting Dated 30Th July 2026. | - |
| 2026-07-03 | Certificate Under Reg. 74 (5) Of SEBI (DP) Regulations 2018 | - |
| 2026-06-24 | Closure of Trading Window | - |
| 2026-05-30 | Announcement under Regulation 30 (LODR)-Change in Management | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹16.07, within a 52-week range of ₹12.31 to ₹19.69. The P/E ratio is -46.35 and the P/B ratio is -1.14, with earnings per unit of ₹-0.28. Market capitalisation stands at ₹16.25 Cr. The company operates in the Commercial Services sector, in the Trading & Distributors industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.